“ If you compare pharma industry development to a series of gold rushes, the pharma companies are the ones panning for the gold and we are the… ”
In Conversation
“ The past six months have been significant. We held two successful high-level meetings, one with Premier Li Keqiang and one with Vice Premier Hu Chunhua. Being… ”
“ China has always been a tough and complex market but I would say that in recent years, it has become tougher, notably due to the reforms… ”
“ We look forward to the acceleration of registration processes as well as the harmonization of China’s regulatory requirements with more developed and mature countries ”
Pierre Faury – Co-President, French Healthcare Alliance and VP (Commercial Excellence), Sanofi China
“ You cannot come to China with the expectation that you will copy and paste what you have done in other markets ”
“ Here in China, it is equally important to remember to focus on employees and the employee journey. Without happy and productive employees, the company cannot grow! ”
“ Now that China is a part of ICH, the Chinese biotech sector will be exposed to uniform global regulatory and technical development standards. ”
“ We cannot focus only on the Chinese market. China may be the second-largest pharmaceutical market in the world but it still represents only 10 percent of… ”
“ Having the right organization and the right people is critical to success ”
“ We have been chosen as ‘IPO of the Year’ by the leading finance magazine in Asia, International Financing Review (IFR) Asia! But in terms of Innovent’s journey,… ”
“ This is how I like to look at it: yes, the regulatory system is different here – as it is everywhere. The financial system is different… ”
“ The global R&D and innovation system often involves close collaboration between big multinationals, capital and local start-ups – and this sort of environment is developing in… ”
